Pharming Group N.V.
PHGUF
$0.90
$0.1113.92%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 245.32M | 218.72M | 206.26M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 245.32M | 218.72M | 206.26M | |
| Cost of Revenue | -- | 25.21M | 24.37M | 18.37M | |
| Gross Profit | -- | 220.10M | 194.35M | 187.89M | |
| SG&A Expenses | -- | 175.26M | 160.16M | 156.55M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | 19.01M | 11.59M | 11.29M | |
| Total Operating Expenses | -- | 288.15M | 264.30M | 245.95M | |
| Operating Income | -- | -42.83M | -45.58M | -39.69M | |
| Income Before Tax | -- | -12.01M | -28.06M | -22.07M | |
| Income Tax Expenses | -- | -1.46M | -6.01M | -5.65M | |
| Earnings from Continuing Operations | -- | -10.55 | -22.06 | -16.42 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -10.55M | -22.06M | -16.42M | |
| EBIT | -- | -42.83M | -45.58M | -39.69M | |
| EBITDA | -- | -28.71M | -32.05M | -25.97M | |
| EPS Basic | -- | -0.02 | -0.04 | -0.03 | |
| Normalized Basic EPS | -- | -0.03 | -0.04 | -0.04 | |
| EPS Diluted | -- | -0.02 | -0.04 | -0.03 | |
| Normalized Diluted EPS | -- | -0.03 | -0.04 | -0.04 | |
| Average Basic Shares Outstanding | -- | 2.68B | 2.63B | 2.58B | |
| Average Diluted Shares Outstanding | -- | 2.68B | 2.63B | 2.63B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
